These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1756381)
1. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease. Schröder H; Giacobini E; Struble RG; Luiten PG; van der Zee EA; Zilles K; Strosberg AD Brain Res Bull; 1991 Nov; 27(5):631-6. PubMed ID: 1756381 [TBL] [Abstract][Full Text] [Related]
2. Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease. Schröder H; Giacobini E; Struble RG; Zilles K; Maelicke A; Luiten PG; Strosberg AD Ann N Y Acad Sci; 1991; 640():189-92. PubMed ID: 1776738 [TBL] [Abstract][Full Text] [Related]
3. Human cortical neurons contain both nicotinic and muscarinic acetylcholine receptors: an immunocytochemical double-labeling study. Schröder H; Zilles K; Luiten PG; Strosberg AD; Aghchi A Synapse; 1989; 4(4):319-26. PubMed ID: 2603150 [TBL] [Abstract][Full Text] [Related]
4. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Schröder H; Giacobini E; Struble RG; Zilles K; Maelicke A Neurobiol Aging; 1991; 12(3):259-62. PubMed ID: 1876232 [TBL] [Abstract][Full Text] [Related]
5. Cholinoceptive cells in rat cerebral cortex: somatodendritic immunoreactivity for muscarinic receptor and cytoskeletal proteins. Woolf NJ J Chem Neuroanat; 1993; 6(6):375-90. PubMed ID: 7511392 [TBL] [Abstract][Full Text] [Related]
7. Visualization of cholinoceptive neurons in the rat neocortex: colocalization of muscarinic and nicotinic acetylcholine receptors. van der Zee EA; Streefland C; Strosberg AD; Schröder H; Luiten PG Brain Res Mol Brain Res; 1992 Aug; 14(4):326-36. PubMed ID: 1326695 [TBL] [Abstract][Full Text] [Related]
8. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Lai MK; Lai OF; Keene J; Esiri MM; Francis PT; Hope T; Chen CP Neurology; 2001 Sep; 57(5):805-11. PubMed ID: 11552008 [TBL] [Abstract][Full Text] [Related]
10. Acetylcholine receptor targets on cortical pyramidal neurones as targets for Alzheimer's therapy. Chessell JP Neurodegeneration; 1996 Dec; 5(4):453-9. PubMed ID: 9117562 [TBL] [Abstract][Full Text] [Related]
11. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096 [TBL] [Abstract][Full Text] [Related]
12. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease. Scarr E; McLean C; Dean B J Neural Transm (Vienna); 2017 Mar; 124(3):273-284. PubMed ID: 27688247 [TBL] [Abstract][Full Text] [Related]
13. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Muma NA; Mariyappa R; Williams K; Lee JM Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374 [TBL] [Abstract][Full Text] [Related]
14. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742 [TBL] [Abstract][Full Text] [Related]
15. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Wevers A; Burghaus L; Moser N; Witter B; Steinlein OK; Schütz U; Achnitz B; Krempel U; Nowacki S; Pilz K; Stoodt J; Lindstrom J; De Vos RA; Jansen Steur EN; Schröder H Behav Brain Res; 2000 Aug; 113(1-2):207-15. PubMed ID: 10942047 [TBL] [Abstract][Full Text] [Related]
16. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. Mufson EJ; Jaffar S; Levey AI J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920 [TBL] [Abstract][Full Text] [Related]
17. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Svensson AL; Alafuzoff I; Nordberg A Brain Res; 1992 Nov; 596(1-2):142-8. PubMed ID: 1467980 [TBL] [Abstract][Full Text] [Related]
18. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Ladner CJ; Lee JM Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152 [TBL] [Abstract][Full Text] [Related]
19. Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease. Hérnandez-Hérnandez A; Adem A; Ravid R; Cowburn RF Neurosci Lett; 1995 Feb; 186(1):57-60. PubMed ID: 7783950 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of muscarinic acetylcholine receptor-like immunoreactivity in the rat forebrain and upper brainstem. van der Zee EA; Matsuyama T; Strosberg AD; Traber J; Luiten PG Histochemistry; 1989; 92(6):475-85. PubMed ID: 2807994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]